For the first time in U.S. history, the Census Bureau projects that by 2035 seniors will outnumber children. And as the population grays, a cloud of uncertainty over rising healthcare costs looms over the near horizon.
Healthcare spending is projected to accelerate over the next decade, and 60 percent of American adults are now living with at least one chronic condition. Chronic diseases like asthma, cancer, diabetes, and heart disease cost Georgia about $40 billion a year.
Steven Stice, GRA Eminent Scholar of Regenerative Medicine at the University of Georgia and a researcher with the Petit Institute for Bioengineering and Bioscience at Georgia Tech, believes one solution to combat the cost of chronic disease is to produce cell-based therapies in much larger quantities and more consistent quality.
And he isn’t alone.